Prosthetic Heart Valves Market In-Depth Analysis And Future Forecast 2018-2026

Heart valves play an important role in controlling the blood flow to and from the heart. The heart consists of four main types of valves that are tricuspid, pulmonary, mitral, and aortic valves. Prosthetic heart valves are commonly known as artificial valves that implanted in the heart of the patients suffering from the valvular heart disease. Thus, the surging incidence of heart disorders drives the prosthetic heart valve market over the forecast period. There are 3 types of prosthetic heart valve such as mechanical heart valve, tissue heart valve, and transcatheter heart valve.

Market DynamicsThe aging population and increasing patient population of heart disease are expected to drive demand for prosthetic heart valve-based treatment in the future. For instance, According to the statistics of World Health Organization in 2012, 17.6 million people died of cardiovascular disease (CVD) worldwide, and proportionally, this accounts for 31.43% of global mortality. Moreover, The emergence of valve-in-valve procedures serves as a significant market opportunity for the prosthetic heart valve. Physicians are opting to use bioprosthetic valves because they are confident that in the case of tissue valve degeneration, they will be able to re-intervene and percutaneously implant a transcatheter valve. Given the high treatment costs associated with Transcatheter Aortic Heart Valve (TAVR), strict regulations by the government may restraint the market growth during the forecast period.

Request For a Sample Copy of This Research Report: https://www.coherentmarketinsights.com/insight/request-sample/69

Key features of the study:

• This report provides in-depth analysis of prosthetic heart valves in medical sector and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global prosthetic heart valves market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans

Growing Aging Population and prevalence of valvular disease spur growth of the prosthetic heart valve marketIncreasing geriatric population and prevalence of valvular heart disease will boost the demand of prosthetic heart valves market. According to the National Centre for Health Statistics, 2011, Heart disease is the leading cause of death in the U.S., killing more than 600,000 Americans each year. Continue focusing to advance surgical replacement technologies for patients with diseased, damaged or malfunctioning heart valves by manufacturers is expected to create a lucrative opportunities for the market over the forecast period. For instance, in 2017, Edwards Lifesciences Corporation received U.S. FDA approval for aortic and mitral valve-in-valve procedures using the Edwards SAPIEN 3 transcatheter heart valve.

The growth of prosthetic heart valve market size in Asia is expected to be high in the near future due to increasing incidence of various chronic diseases and improving healthcare infrastructure in this region. According to a study published in the Lancet—a U.K.-based medical journal, 2016—the number of people affected by high blood pressure has almost doubled over past 40 years (from 1975 to 2015) worldwide.However, the largest rise in the prevalence of adults with high blood pressure has been in low- and middle-income countries (LMICs) in south Asia (eg, Bangladesh and Nepal) and sub-Saharan Africa (eg, Ethiopia and Malawi). Moreover, in according to EurekAlert global news, In 2015, over half (590 million) of adults with high blood pressure lived in east, southeast and south Asia--of whom 199 million lived in India and 226 million in China.

The key players operating in the global prosthetic heart valves market include Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronic plc, LivaNova PLC, Abbott, Jenavalve Technology, Inc., Lepu Medical Technology Co., Ltd., CryoLife, Inc., and Neovasc Inc.

Click To Read More On Prosthetic Heart Valves Market

About Coherent Market Insights:Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.